These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1384461)

  • 1. Systemic antiangiogenic therapy for choroidal neovascularization. What is the role of interferon alfa?
    Guyer DR; Adamis AP; Gragoudas ES; Folkman J; Slakter JS; Yannuzzi LA
    Arch Ophthalmol; 1992 Oct; 110(10):1383-4. PubMed ID: 1384461
    [No Abstract]   [Full Text] [Related]  

  • 2. Interferon alfa-2a is ineffective for patients with choroidal neovascularization secondary to age-related macular degeneration. Results of a prospective randomized placebo-controlled clinical trial. Pharmacological Therapy for Macular Degeneration Study Group.
    Arch Ophthalmol; 1997 Jul; 115(7):865-72. PubMed ID: 9230826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon alfa-2a in the treatment of subfoveal choroidal neovascularization.
    Thomas MA; Ibanez HE
    Am J Ophthalmol; 1993 May; 115(5):563-8. PubMed ID: 7683842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon for subfoveal choroidal neovascularisation.
    Groeneveld E; Eliadis P
    Aust N Z J Ophthalmol; 1993 May; 21(2):133-4. PubMed ID: 7687445
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of choroidal neovascularisation in age-related macular degeneration with interferon alfa-2a and alfa-2b.
    Gillies MC; Sarks JP; Beaumont PE; Hunyor AB; McKay D; Kearns M; McClusky PJ; Sarks SH
    Br J Ophthalmol; 1993 Dec; 77(12):759-65. PubMed ID: 7509184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon alfa-2a modifies the course of subfoveal and juxtafoveal choroidal neovascularisation.
    Engler C; Sander B; Villumsen J; Lund-Andersen H
    Br J Ophthalmol; 1994 Oct; 78(10):749-53. PubMed ID: 7528534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical experience with interferon alfa-2a for exudative age-related macular degeneration.
    Kirkpatrick JN; Dick AD; Forrester JV
    Br J Ophthalmol; 1993 Dec; 77(12):766-70. PubMed ID: 7509185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. We are very spoiled.
    Fine SL; Maguire MG
    Arch Ophthalmol; 1997 Jul; 115(7):915-6. PubMed ID: 9230835
    [No Abstract]   [Full Text] [Related]  

  • 9. Systemic interferon-alpha 2a and subretinal neovascular membranes.
    Constable I
    Aust N Z J Ophthalmol; 1992 Aug; 20(3):155. PubMed ID: 1280446
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of choroidal neovascularization in age-related macular degeneration with interferon alpha-2a: a short term, nonrandomized pilot study.
    Thoelen A; Menozzi M; Huber C; Messmer E
    Ger J Ophthalmol; 1995 May; 4(3):137-43. PubMed ID: 7545047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of interferon-beta on experimental choroidal neovascularization].
    Tobe T; Takahashi K; Ohkuma H; Uyama M
    Nippon Ganka Gakkai Zasshi; 1995 May; 99(5):571-81. PubMed ID: 7540359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current treatment of choroidal neovascularization in age-related macular degeneration].
    Donati G
    J Fr Ophtalmol; 2002 Sep; 25(7):740-6. PubMed ID: 12399734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravitreal interferon alpha-2b for the treatment of neovascular age-related macular degeneration: a pilot study.
    Kertes PJ; Britton WA; Leonard BC
    Can J Ophthalmol; 1997 Apr; 32(3):185-8. PubMed ID: 9131284
    [No Abstract]   [Full Text] [Related]  

  • 14. Current management of choroidal neovascularization.
    Singerman LJ
    Ann Ophthalmol; 1988 Nov; 20(11):415-20, 423. PubMed ID: 2466432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Choroidal (subretinal) neovascularization secondary to choroidal nevus and successful treatment with argon laser photocoagulation. Case reports and review of literature.
    Mines JA; Freilich DB; Friedman AH; Lazar M
    Ophthalmologica; 1985; 190(4):210-8. PubMed ID: 2409499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrence of a choroidal neovascular membrane in a patient with punctate inner choroidopathy treated with daily doses of thalidomide.
    Ip M; Gorin MB
    Am J Ophthalmol; 1996 Oct; 122(4):594-5. PubMed ID: 8862067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-associated retinopathy.
    Guyer DR; Tiedeman J; Yannuzzi LA; Slakter JS; Parke D; Kelley J; Tang RA; Marmor M; Abrams G; Miller JW
    Arch Ophthalmol; 1993 Mar; 111(3):350-6. PubMed ID: 8447745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presumed macular choroidal watershed vascular filling, choroidal neovascularization, and systemic vascular disease in patients with age-related macular degeneration.
    Ciulla TA; Harris A; Danis RP
    Am J Ophthalmol; 1998 Jul; 126(1):153-5. PubMed ID: 9683172
    [No Abstract]   [Full Text] [Related]  

  • 19. Choroidal neovascularization associated with choroidal hemangiomas.
    Ruby AJ; Jampol LM; Goldberg MF; Schroeder R; Anderson-Nelson S
    Arch Ophthalmol; 1992 May; 110(5):658-61. PubMed ID: 1374608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of FasL in retinal pigment epithelial cells reduces choroidal neovascularization.
    Semkova I; Fauser S; Lappas A; Smyth N; Kociok N; Kirchhof B; Paulsson M; Poulaki V; Joussen AM
    FASEB J; 2006 Aug; 20(10):1689-91. PubMed ID: 16807368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.